We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Global Orphan Drugs And Rare Diseases Summit

Curtis & Wyss Group is pleased to invite you to the Global Orphan Drugs and Rare Diseases Summit scheduled for March 2 – 3, 2017 in Barcelona.

This event will bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers to review recent developments in the orphan drug and rare diseases industry, to learn and discuss the most pressing topics, benchmark best practices with their peers and discover the future of orphan drug research, development and manufacture.

The Summit will be focusing on the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.

Our experts will be leading discussions covering how payers, pharmaceutical, biotech, patient organisations and academia are structuring to participate in and leverage the growing orphan drugs and rare diseases market.

It is an honor and privilege to invite you to participate in this Summit. We look forward to welcome you in Barcelona upcoming March!

 

Key Practical Learning Points of the Summit:

  • Drug Development and Market Challenges
  • Innovative strategies to incorporate the patient perspective and accelerate orphan drug development
  • Pricing, Reimbursement and Market Access Challenges for Advanced Therapy Medicinal Product & Orphan Drugs in the EU
  • Accelerating Commercialization of Rare Disease Treatments
  • Regulatory Pathway for Rare Disease treatments

Why should you be there?

  • Develop key relationships and meet with 450+ potential customers who need to find solutions to challenges around the commercial, regulatory and scientific issues in orphan drugs
  • Discuss how to better distribute your products and gain market access
  • Learn about key strategies and collaborations to accelerate rare disease clinical drug development
  • Enhance your knowledge on the role of patient organizations in promoting drug development for their disease
  • Interact and connect with leading companies in Orphan Drug and Rare Diseases industry

Who should attend?

  • CROs
  • CMOs
  • Market Access Consultancies
  • Regulatory Affairs Consultancies
  • Big Pharma and Biotech
  • Platform Technology Providers
  • OEM / Equipment Providers
  • Academia
  • Non-Profit Organisations

When

2 March 2017 @ 08:30 am

3 March 2017 @ 05:00 pm

Duration: 1 days, 8 hours

Where

Barcelona

Barcelona, Spain

13000 Barcelona

Spain

Organised by

Curtis Wyss (view profile)

Similar Events in Health

The Health Technology Assessment Course

Belgium, 30 November 2017

Similar Webinars in Health

Recent Publications in Health

Childhood Obesity

Policy Recommendation, beuc.eu , March 2017

Recent Videos in Health

Recent News in Health

#Microplastics and #nanoplastics in food – Which foods contain these materials? https://t.co/QIL1bf3Z2n https://t.co/hhI2aKlWVK

@EFSA_EU - 27 March 2017 14:18

eUROGEN: the #ERN for rare urogenital diseases/complex conditions needing highly specialised assessment & surgery… https://t.co/xFMVf8cdy9

@EU_Health - 27 March 2017 12:07

Good governance at #EFSA: the Management Board. Watch the video to find out more https://t.co/w901uUb7Ii

@EFSA_EU - 27 March 2017 11:59

What has Europe ever done for health? Editorial on the 60th anniversary of the Treaty of Rome #EU60… https://t.co/DygHZVEF8G

@EFSA_EU - 27 March 2017 09:38

Peace, freedom, tolerance, solidarity, rule of law. Look back w. pride, look forward with hope #EU60… https://t.co/R4tn7fC94k

@Food_EU - 25 March 2017 15:07